USPTO serial 79277036
RTM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 22, 2020
- Examiner
- DINALLO, KEVIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RTM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; Veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; Pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; Pharmaceutical preparations, namely, antibodies used for the testing of the disease; Vaccines; Diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; Pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; Hygiene preparations for medical use, namely, disinfectants; Biocides; Diagnostic preparations for medical or veterinary use; Sanitary towels for hygiene purposes; Dietetic foods for medical use; Dietetic beverages for medical use; Biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; Anti-bacterial preparations, namely, anti-bacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; Protein dietary supplements | ACTIVE | — |
| 042 | Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; Research in the field of pharmaceutical products, cosmetics and foodstuffs for others; Advisory and information services in the field of monitoring and control for purposes of quality control and analysis of biologically active chemicals; Research in the field of medical treatment and medical methods; Research in the field of biotechnology and antibodies; Medical and scientific research in the field of clinical trial review and research with regard to medical treatment; Research in the field of sanitary care; Monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; Software design; Computer programming; Maintenance of software; Design and development of computer hardware; Software development; Consultancy and providing of information with respect to quality control of pharmaceutical products; Scientific research in the field of cancerous diseases; Scientific research with respect to chemistry | ACTIVE | — |
| 044 | Medical services; Medical services in the field of immunity; Provision of medical information; Medical examinations, namely, physical examinations for medical purposes; Pharmaceutical consulting in the manufacture of medicines; Services provided by consultants in nutrition and dietetics; Consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; Veterinary services; Beauty salon services; Animal care services, namely, veterinary care services; Medical consulting services for hygiene in the field of care; Medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; Consulting services with respect to preparation and administration of pharmaceutical products; Providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; Drug testing, namely, systematic testing of medicinal products for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RTM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 4, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 21, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 21, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 21, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 23, 2021 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 22, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 22, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 27, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 31, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2020 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |